Fermentation Process Advantages and Financial Highlights

0 Strong & Niche Product Portfolio - Growing at pace Rifamycin S Current Product Portfolio GB ■ An intermediate for manufacturing drug Rifampicin (Anti biotic used for treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease) ◉ Capacity of Rifamycin S is 10,000 Kgs/Month An intermediate for manufacturing drug Rifaximin (Antibiotic used for treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy) Capacity of Rifamycin O is 6,000 Kgs/Month Rifamycin ◉ ☐ ☐ Identified and working developing four New Products and adding to portfolio Developing them all by self All specialised products and add huge value to portfolio Demand side remains pretty strong for products manufactured by GTBL -more than decade old products - no replacement for these - continue to be most accepted and preferred prodcust with growing demand 10

View entire presentation